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We have cloned Pfnek-1, a gene encoding a novel protein
kinase from the human malaria parasite Plasmodium
falciparum. This enzyme displays maximal homology
to the never-in-mitosis/Aspergillus (NIMA)/NIMA-like
kinase (Nek) family of protein kinases, whose members
are involved in eukaryotic cell division processes. Similar
to other P. falciparum protein kinases and many enzymes
of the NIMA/Nek family, Pfnek-1 possesses a large
C-terminal extension in addition to the catalytic domain.
Bacterially expressed recombinant Pfnek-1 protein is able
to autophosphorylate and phosphorylate a panel of protein
substrates with a specificity that is similar to that displayed
by other members of the NIMA/Nek family. However, the
FXXT motif usually found in NIMA/Nek protein kinases
is substituted in Pfnek-1 by a SMAHS motif, which is
reminiscent of a MAP/ERK kinase (MEK) activation site.
Mutational analysis indicates that only one of the serine
residues in this motif is essential for Pfnek-1 kinase activity
in vitro. We show (a) that recombinant Pfnek-1 is able to
specifically phosphorylate Pfmap-2, an atypical P. falci-
parum MAPK homologue, in vitro, and (b) that coincuba-
tion of Pfnek-1 and Pfmap-2 results in a synergistic
increase in exogenous substrate labelling. This suggests
that Pfnek-1 may be involved in the modulation of MAPK
pathway output in malaria parasites. Finally, we demon-
strate that recombinant Pfnek-1 can be used in inhibition
assays to monitor the effect of kinase inhibitors, which
opens the way to the screening of chemical libraries aimed
at identifying potential new antimalarials.
Keywords: Plasmodium falciparum; malaria; protein
kinase; signal transduction; phosphorylation.
Plasmodium falciparum, the protozoan parasite responsible
for the lethal form of human malaria, causes 1.5±2.7
million deaths every year, mostly among children in
subsaharan Africa. Most of the human population in
tropical and subtropical regions is at risk, with several
hundred million cases declared annually. The impact of this
parasite on the socio-economic development of affected
countries is considerable, and increasing as a result of the
spread of drug resistance in P. falciparum. The fight against
malaria is now viewed as a priority by many national and
international biomedical organizations, which has stimu-
lated research aimed at identifying novel control agents
(reviewed in [1]).
Infection of humans by P. falciparum is initiated by
injection of sporozoites into the bloodstream by an
Anopheles mosquito. Sporozoites rapidly invade hepato-
cytes, where a first round of asexual division (exoerythro-
cytic schizogony) occurs, leading to the release of several
thousand merozoites into the bloodstream. These mero-
zoites invade erythrocytes, where they undergo asexual
multiplication (erythrocytic schizogony) yielding 8±32 new
merozoites. Instead of producing new schizonts, some
merozoites, after invasion of the erythrocyte, arrest their
cell cycle and develop into male or female gametocytes, the
forms that are required for transmission to the mosquito
(asexual parasites do not survive ingestion by the insect). In
the mosquito midgut, gametocytes are activated, leading to
the formation of fertilization-competent gametes. After
fertilization, the zygote undergoes meiotic reduction and a
succession of developmental stages which ultimately results
in the accumulation of sporozoites in the insect's salivary
glands (reviewed in [1,2]).
We are engaged in a study of the molecular mechanisms
regulating parasite multiplication and development. We
focus our attention on protein kinases involved in the
control of the cell cycle, and in those signal transduction
pathways that have been shown in other eukaryotes to affect
the division status of the cell [3]. In this context, we have
identified Pfmap-1 [4] and Pfmap-2 [5], two mitogen-
activated protein kinase (MAPK) homologues from the
parasite. MAPKs, also called ERKs (extracellularly regulated
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kinases), play central roles in the adaptative response of
eukaryotic cells to a wide range of stimuli (reviewed in [6])
They are activated by dual Thr and Tyr phosphorylation of
the conserved MAPK activation site, Thr-X-Tyr, by a
specific MEK (MAPK/ERK kinase). Pfmap-1 and Pfmap-2
are most closely related to the ERK1/ERK2 subfamily,
whose members are involved in the regulation of cell
proliferation/differentiation in response to external stimuli.
Pfmap-1 is expressed both in asexual parasites and in
gametocytes [4,7,8], and contains the conserved Thr-X-Tyr
activation site. In contrast, Pfmap-2 mRNA and protein are
detectable only in gametocytes, and the enzyme presents an
atypical Thr-Ser-His motif in place of the expected Thr-X-
Tyr activation site. Site-directed mutagenesis showed that
both the Thr and the His residues in this motif are important
for kinase activity of recombinant Pfmap-2 [5]. This
atypical feature suggests that the modalities of activation
of Pfmap-2 may differ from that of `regular' MAPKs.
The NIMA enzyme (`never in mitosis/Aspergillus') was
first identified in the filamentous fungus Aspergillus
nidulans as a cyclin-independent serine/threonine kinase
required for entry into mitosis (temperature-sensitive
mutants arrest the cell cycle in G2, hence the name
`never in mitosis') ([9,10], for a review on NIMA/NIMA-
like kinase (Nek) kinases, see [11]). Overexpression of
NIMA results in premature onset of mitotic phenomena,
such as chromatin condensation [12] and formation of
abnormal mitotic spindles [9]. Protein kinases with
maximal homology to NIMA have been found in other
eukaryotes: Saccharomyces cerevisiae Kin3/NPK1 [13,14],
Schizosaccharomyces pombe fin1 [15], Trypanosoma
brucei NrkA and NrkB [16] and a family of NIMA-related
kinases (Nek1, Nek2, Nek3 and Stk2) identified in
mammalian cells ([17±20], reviewed in [11]). The only
heterologous gene demonstrated to complement the nimA
temperature-sensitive mutation is nim-1 from the fila-
mentous fungus Neurospora crassa [21], indicating that
enzymes of this family may have different functions despite
structural similarity. Indeed, yeast Kin3 and fin1 are
nonessential [13±15], suggesting that they are not true
homologues of NIMA (although fin1 appears to play a role
in chromatin condensation, a feature shared by NIMA). In
line with these data, the mammalian Neks appear to have
distinct functions: both Nek1 and Nek2 are expressed
predominantly in testis, albeit at different stages of
spermatogenesis, suggesting different roles in meiotic
regulation; Nek2 is associated with the centrosome, the
structure of which is affected by overexpression of Nek2
[22]. In contrast, Nek3 is expressed in all tissues tested, and
its activity is not regulated in a cell cycle-dependent way
[18].
Here, we report the biochemical characterization of
Pfnek-1, a novel P. falciparum protein kinase with maximal
homology to the kinases of the Nek family. The reason we
became interested in Pfnek-1 is that it contains a region not
shared by Neks from other eukaryotes that is similar to an
activation site conserved among MEKs. Pfnek-1 was the
only kinase with such an MEK-like activation site found in
the PlasmoDB database (http://plasmodiumdb.cis.upenn.
edu/), which includes all available data from the Plasmo-
dium Genome Project, and where . 90% of the parasite's
genes were represented at the time of writing [22a]. Bio-
chemical and mutagenesis data confirm the relatedness of
Pfnek-1 to members of the Nek family. In line with the
presence of a MEK-like feature in its primary structure, we
show that recombinant Pfnek-1 has the ability to phosphory-
late Pfmap-2 (but not Pfmap-1 nor ERK2, a mammalian
MAPK). Furthermore, our data show that coincubation of
Pfnek-1 and Pfmap-2 results in a synergistic increase in
kinase activity.
M A T E R I A L S A N D M E T H O D S
Northern blot analysis
Total RNA was extracted from asynchronous asexual
parasites and from Percoll-purified gametocytes using the
Quiagen RNeasy kit following the manufacturer's instruc-
tions. Approximately 5 mg of total RNA from each stage
were fractionated on an agarose-formaldehyde gel follow-
ing standard protocols [23] and transferred onto C-extra
nitrocellulose. Prehybridization and hybridization were
performed as described previously [24], using 32P-labelled
probes obtained by random priming of PCR products.
Molecular cloning of His-Pfmap-2
The Pfmap-2 ORF lacking the N-terminal extension (i.e.
the 97 first codons as starting from the first ATG, see [5])
was amplified from the pGEX±Pfmap-2 [5] using the
following primers: forward: GGGAGATCTAAAAATGTA
AAAGGTACCAGATAAT; reverse: GGGAGATCTCATAT
TGTAGAAACTTTTTTGATG (Bgl II sites are underlined).
The PCR product was digested with Bgl II and cloned into
the BamH1 site of the pQE12 vector (Quiagen). The
resulting pQE12-Pfmap-2 construct was verified by DNA
sequencing prior to bacterial expression in Escherichia coli.
Molecular cloning of Pfnek-1 and site-directed
mutagenesis
Oligonucleotides were designed to amplify from P. falci-
parum (clone 3D7) genomic DNA the N-terminal part of
the Pfnek-1 ORF identified on chromosome 11, using the
Taq polymerase from Takara. The forward (ATGATGG-
GATCCTTATGCCAAGTAAATATGATGATGGA) and
reverse (ATGATGGAATTCTCAAGAGCCTTTCTCTGAC
TCCTCT) primers carried BamHI and EcoRI sites,
respectively (underlined). The1400-bp amplified product
was digested with BamHI and EcoRI and inserted into
the pGEX-3X vector (Pharmacia) digested by the same
enzymes. The insert was sequenced prior to expression of
the recombinant protein in E. coli (strain BL21). To obtain
plasmids encoding various mutants of Pfnek-1, site directed
mutagenesis was performed by overlap extension [25]. The
following mutated plasmids were constructed: (a) lysine to
methionine change at residue 44 (K44M); (b) serine to
alanine change at residue 196 (S196A); (c) serine to alanine
change at residue 200 (S200A). The plasmids were
sequenced to verify that no additional mutations had been
generated during the PCR procedure.
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Bacterial expression and purification of recombinant
fusions proteins
Glutathione-S-transferase (GST) fusions proteins. Expres-
sion and purification of GST-Pfmap2, and of wild-type and
mutated GST±Pfnek-1, were performed as described
previously for GST-Pfmap2 [5].
His-Pfmap-2. An overnight culture of bacteria carrying the
PQE12-Pfmap-2 vector was diluted 50-fold in 2YT medium
supplemented with 100 mg´mL21 ampicillin and 25 mg´mL
kanamycin. At D600  0.6, expression was induced by
addition of 0.2 mm of isopropyl thio-b-d-galactoside
(IPTG) and grown for an additional 5 h at 30 8C. Cells
were collected by centrifugation and lysed by sonication in
sonication buffer [25 mm TrisHCl (pH 8.0), 300 mm NaCl,
5 mm imidazole, 1 mm phenylmethanesulfonylfluoride plus
the complete inhibitorTM cocktail tablet (Boehringer
Mannheim)]. The lysate was incubated with Ni/nitriloacetic
acid beads (Quiagen) for 1 h at 4 8C. The nickel beads were
washed four times in sonication buffer containing 60 mm
imidazole and bound proteins were eluted twice in elution
buffer (sonication buffer plus 250 mm imidazole). After
concentration on Centricon 10, the His/Pfmap-2 protein
was stored at 220 8C in 50% glycerol.
Kinase assays
Unless stated otherwise, kinase reactions (30 mL) were
performed in a standard kinase buffer containing 20 mm
Tris/HCl (pH 7.5), 20 mm MgCl2, 2 mm MnCl2, 10 mm
ATP, 5 mCi [g-32P]ATP, using 0.5 mg of recombinant
kinase and 5 mg of substrate (GST, b-casein, a-casein,
myelin basic protein or histone). After 30 min at 30 8C, the
reaction was stopped by addition of Laemmli buffer and
loaded on a 12% SDS/polyacrylamide gel. Following
Coomassie blue staining, the gels were dried and exposed
for autoradiography.
Determination of kinetic parameters
The assays were carried out as above except that 0.5 mCi
[g-32P]ATP were used instead of 5 mCi (the determination
of Vmax was achieved with standard kinase assays using a
range of substrate concentrations (b-casein) in the presence
of 100 mm ATP and 5 mCi [g-32P]ATP). 25 mL of each
reaction were withdrawn at different times and spotted on a
piece of Whatman phosphocellulose paper. The paper was
washed five times in 1% orthophosphoric acid, and the
amount of precipitable radiolabel incorporated into protein
was measured in a scintillation counter.
Inhibition assays
The effect of protein kinase chemical inhibitors on Pfnek-1
kinase activity was tested in kinase reactions in the
presence of Pfnek-1 (20 ng), b-casein (5 mg) as a substrate,
0.05 mCi [g-32P]ATP and increasing concentrations of each
inhibitor (stocks solutions of the chemical compounds were
at 1 mm in dimethylsulfoxide; and the concentration of
DMSO was identical in all reactions). From each reaction,
25 mL were spotted on Whatman phosphocellulose paper
and treated as described above.
R E S U L T S
Molecular cloning of Pfnek-1
In order to experimentally identify a P. falciparum MEK
homologue, we performed an extensive series of low
stringency PCR experiments with a battery of degenerate
Fig. 1. Amino-acid sequence of the Pfnek-1 ORF. The N-terminal
313 residues are aligned to the catalytic domains human Nek2 (Hs
Nek2), mouse Nek1 (Mm Nek1) and A. nidulans NIMA (NIMA).
Residues in these three proteins which are identical to that in Pfnek-1
are indicated by (.), and gaps introduced to maximize alignment are
indicated by (±). Alignment was performed using the multalin
program. The conserved MEK activation site of mouse MEK1
(SMANS) is indicated above the NIMA /nek activation site (FXXT),
and protein kinase signatures are underlined. The amino acids that are
`invariant' in serine/threonine protein kinases are labelled with an (o).
Percent identity values are indicated for residues 1±298, including (left
column) or excluding (right column) the 20-residue insertion in
Pfnek-1. The C-terminal extension is shown without alignment, and the
regions containing the repeated motifs are boxed (see text for details).
Sequence data are from the TIGR and PlamsoDB databases; we
verified only the sequence encoding residues 1±432, which was cloned
in the expression plasmid.
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primers targeted at conserved MEK sequences, using
P. falciparum genomic DNA and cDNA as templates.
Despite enabling us to unexpectedly identify genes from
other kinase families (notably Pfmap-2 [5]), this approach
was not successful in its primary goal, the identification of
a MEK homologue. Taking advantage of the fact that
most of the parasite's genome sequence has been made
available to the research community in the context of the
P. falciparum Genome Project, we performed BLAST
analyses against the Genome Project databases using
whole-length MEK sequences from various organisms as
queries. This did not allow us to find any genes that were
obvious MEK orthologues. We therefore repeated the
BLAST searches, using as queries not the entire coding
sequences of MEKs, but a short region of human MEK1 (23
residues: GVSGQLIDSMANSFVGTRSYMSP) spanning
the activation site that is conserved in MEK1 and MEK2
family members [26] (the two Ser residues whose phos-
phorylation by MEKK causes activation of the MEK are
underlined), reasoning that focussing on this region might
enable us to home in on a MEK functional homologue even
if its sequence were divergent from MEKs in other regions.
The only hit sequence we obtained corresponded to a series
of clones (shotguns and contigs) from chromosome 11,
currently being sequenced by The Institute for Genome
Research. Assembly of overlapping contigs and shotguns
allowed us to show that the sequence identified in the
BLAST analysis was included in a 2988-bp ORF, poten-
tially encoding a 996 amino-acid protein with a predicted
molecular mass of 117 944 Da. The sequences immediately
adjacent to the ORF are rich in adenosine and thymidine
polymeric stretches typical of P. falciparum noncoding
regions, and numerous stop codons in all three frames are
found 3 0 to the ORF. A typical serine/threonine protein
kinase domain is located on the 5 0 region of the ORF
(approximately down to amino acid 320), which contains
most of the residues that are almost invariant in enzymes of
this family. Furthermore, this region displays the two
signatures whose simultaneous presence on the same poly-
peptide is considered as diagnostic for serine/threonine
kinases (Fig. 1) [4]. In addition to the catalytic domain, the
ORF includes a 670 amino-acid C-terminal extension
containing repeated motifs, an organization which is
found in other P. falciparum protein kinases [4,7,24,27].
The repeated motifs of this extension are 14 repeats of
a sequence close to RLDRLEKD, and 7 repeats of a
SNMNNM motif. A region very rich in M and N residues
(with a few MNN repeats) is located between these two sets
of repeats.
BLAST analysis (against generalist databases) of the
kinase domain encoded by the ORF gave highest scores not
with proteins from the MEK family, but with NIMA-related
kinases (Neks). Indeed, this protein, which we called
Pfnek-1, shares 42% identity with murine Nek2 [17] (the
closest relative of Pfnek-1 according to BLAST analysis),
but only approximately 30% with MEKs. BLAST analysis
of the long C-terminal extension, which is rich in charged
amino acids and asparagine residues, did not reveal any
significant homology to other proteins; this is true also for
the C-terminal extensions found in other members of
the NIMA/Nek family [18], and in other kinases of
P. falciparum [4,7,24,27].
Pfnek-1 transcripts during the erythrocytic infection
An RT-PCR experiment aimed at determining whether the
Pfnek-1 gene was expressed during erythrocytic infection
indicated that Pfnek-1 mRNA was present in asexual
parasites (data not shown). This was confirmed by stage-
specific Northern blot analysis using two different labora-
tory clones of P. falciparum (Fig. 2), which showed that the
Fig. 2. Northern blot analysis. Total RNA obtained from asexual
parasites or gametocytes of clone 3D7 was fractionated on a denaturing
gel, blotted and hybridized with a Pfnek-1 probe. Panels with numbers
(1,2 and 3) correspond to the ethidium bromide staining of the gel.
Panels with letters (A, B and C) are the autoradiograms. Ribosomal
28S and 18S RNAs are indicated. Lanes 1 and 2: RNA from asexual
parasites. Lane 3: RNA from gametocytes.
Fig. 3. Activity of recombinant wild-type Pfnek-1 and catalytically
inactive mutant K44M. (A) Kinase assays. The reaction contained the
following proteins: lane 1, b-casein alone; lane 2, GST 1 b-casein;
lane 3, GST±Pfnek-1 (0.5 mg) alone; lane 4, GST±Pfnek-1 1 GST
(2 mg); lane 5, GST±Pfnek-1 1 b-casein (100 ng); lane 6, GST±
Pfnek-1-K44M (0.5 mg) alone; lane 7, GST±Pfnek-1-K44M 1
b-casein (100 ng). That similar amounts of wild-type and mutant
proteins were used was verified by Coomassie blue staining of the gel
(not shown). The autoradiogram was exposed for 18 h. B. Kinetic
analysis of Pfnek-1 kinase activity. Reaction rates were determined
after a reaction time of 20 min, which fell into the linear range for all
tested substrate (b-casein) concentrations (not shown). The data are
representative of those from several experiments.
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Pfnek-1 gene is transcribed as a 6.5-kb mRNA that
accumulates in both asexual parasites (lanes A and B)
and gametocytes (lane C), with apparently higher levels in
the latter. Thus, in line with the majority of P. falciparum
mRNAs, the Pfnek-1 message appears to possess extensive
untranslated regions.
Kinase activity of recombinant GST±Pfnek-1
To investigate the enzymatic activity of Pfnek-1, we
expressed the N-terminal half of the Pfnek-1 ORF (residues
1±432, carrying the kinase catalytic domain) in E. coli as a
GST fusion protein, and purified the recombinant protein
on glutathione beads. A protein with the expected 75-kDa
apparent molecular mass was produced, as shown by
Coomassie staining of electrophoresis gels; in addition to
the 75-kDa polypeptide, GST±Pfnek-1 preparations often
contained a cluster of bands at approximately 55 and
30 kDa, which presumably resulted from partial degrada-
tion of the whole-length fusion protein (data not shown).
Kinase assay with GST±Pfnek-1 in the absence of
exogenous substrate resulted in the labelling of the 75-kDa
band (Fig. 3A, lane 3). That this was caused by true
autophosphorylation on the kinase domain rather than by
labelling of the GST moiety was ascertained by the fact
that exogenous GST was not labelled in the presence of
Pfnek-1 (lane 4). To verify that the phosphotransfer onto
GST±Pfnek-1 was indeed mediated by the recombinant
kinase itself (and not by some copurified bacterial kinase
activity), we prepared the mutant GST±Pfnek-1-K44M,
where the Lys44 residue was replaced by a Met. Lys44
corresponds to a residue that is conserved in protein
kinases, and whose substitution with a Met results in a
catalytically inactive mutant in all kinases tested, including
NIMA [28]. The K44M mutant was unable to label the band
at 75 kDa (lane 6), despite displaying a similar pattern in
Coomassie-stained gels (data not shown). Similar to the
mammalian Neks, wild-type GST±Pfnek-1 (but not the
K44M mutant) was able to efficiently phosphorylate
b-casein (Fig. 3A, lanes 5 and 7). The K44M mutant had
no detectable kinase activity on this substrate, even with
high enzyme concentrations and long reaction times (data
not shown). Taken together, these data ascertain that
autophosphorylation occurs with wild-type GST±Pfnek-1,
and that this enzyme is a functional protein kinase which
can use b-casein as a substrate. Determination of GST±
Pfnek-1 kinetic parameters using b-casein as a substrate
(Fig. 3) indicated a Vmax value of 18 nmol phosphate
transferred per min per mg of purified enzyme, varying
slightly with different enzyme preparations, and a Km
value of approximately 15 mm for b casein (for com-
parison, these parameters for the NIMA kinase were
156 nmol´min21´mg21 and 38 mm, respectively [28]).
To investigate whether the structural relatedness of
Pfnek-1 to Nek family members is extended by functional
similarities, we performed kinase assays with a small panel
of substrates (Fig. 4). Essentially, Pfnek-1 substrate speci-
ficity is reminiscent of that of characterized mammalian
Neks [29]: b-casein is an excellent substrate (5 min
exposure is sufficient to give a strong signal on autoradio-
grams in the conditions described in the legend of Fig. 4).
Myelin basic protein (MBP) was a good substrate as well,
whereas a-casein was less efficiently phosphorylated.
Histone H1 was a poor substrate, and GST was not labelled
at all.
To determine whether Pfnek-1 was susceptible to known
protein kinase inhibitors, we performed experiments where
increasing amounts of different molecules were added to
Pfnek-1 kinase assays (Fig. 5). This allowed us to show that
roscovitine (a good inhibitor of cyclin-dependent kinases
[30]) had an IC50 . 10 mm in these conditions, while
compound 97 (a purvalanol derivative [31]) and hymenial-
disine 01 (HD01) [32] had IC50 values of approximately 0.2
and 4 mm, respectively.
Mutational analysis of putative regulatory
phosphorylation sites
NIMA-related kinases share the consensus phosphorylation
site FXXT, in which the threonine residue plays an
important role in enzymatic activity [21]. In line with the
conservation of the overall structure of serine/threonine
protein kinases, in Pfnek-1 this site corresponds precisely to
Fig. 4. Substrate phosphorylation by GST±Pfnek-1. GST±Pfnek-1
kinase assays were performed with 0.5 mg recombinant kinase and
5 mg of the substrates indicated at the top.
Fig. 5. Inhibition of GST±Pfnek-1 by chemical inhibitors. Three
inhibitors were tested (Roscovitine [30], hymenialdisine 01 (HD01)
[32], and the purvalanol-derived compound 97 [31]). The inhibitors
were dissolved in dimethylsulfoxide and added to the kinase assays at a
range of concentrations in such a way that the final concentration of
DMSO was 1% in all tubes. 100% activity corresponds to the Pfnek-1
activity obtained in 1% DMSO without inhibitors. All reactions were
performed in duplicate, and the data indicated here represent the
average values (^ SD) from two independent experiments.
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the `MEK activation site-like' sequence (SMAHS) which
spurred our interest in this protein (see Fig. 1). The
threonine in the FXXT motif is substituted in Pfnek-1 by
the second serine (Ser200) in the SMAHS sequence. To
establish whether the presence of a phosphorylatable
residue at this position is required for kinase activity, we
changed this serine to an alanine by site-directed muta-
genesis. This mutation virtually abolished the kinase
activity of recombinant GST±Pfnek-1 (Fig. 6A); whereas
in the chosen conditions b-casein phosphorylation cata-
lysed by the recombinant wild-type protein increased
linearly (over an hour) with the duration of reaction, the
S200A mutant protein showed very little activity even
over a 1-h reaction time (Fig. 6B). This is in line with the
effect of corresponding mutation (T199A) in nim-1 from
Neurospora crassa [21].
Four residues upstream of the Ser200 residue is another
serine that is also conserved in MEKs (it is one of the two
residues that must be phosphorylated for full MEK
activity); some Neks (e.g. Nek2) also have a serine at this
position (Fig. 1). We addressed the question of its possible
role in kinase activity by substituting this serine with an
alanine. In contrast to the S200A mutation, the S196A
mutation did not significantly affect the catalytic activity of
the enzyme, as the mutant was able to phosphorylate casein
as efficiently as the wild-type (Fig. 6A,B).
The Pfnek-1 mutants were also tested for their ability to
autophosphorylate. The S196A mutant was able to undergo
autophosphorylation in a similar manner to the wild-type
enzyme, whereas autophosphorylation of S200A was
greatly decreased. As expected the K44M mutation leading
to a `kinase dead mutant' dramatically diminished the
transfer of phosphate onto the enzyme (Fig. 6C). These
data are similar to that obtained with the corresponding
mutations in the NIMA enzyme [21]. Measurement of the
amount of 32P transferred per mol of purified wild-type
enzyme through autophosphorylation over long reaction
times strongly suggests that the stoichiometry of the
reaction is 1 mol of phosphate per mol Pfnek-1.
Pfnek-1 phosphorylates Pfmap-2 in vitro
As Pfnek-1 was identified on the basis of a similarity within
a short region spanning the activation of MEKs, we next
wanted to determine whether Pfnek-1 was able to use a
plasmodial MAPK as a substrate in vitro. We first tested the
gametocyte-specific Pfmap-2 enzyme, because (a) Pfnek-1
mRNA appears to accumulate preferentially in gametocytes
such as Pfmap-2, and (b) Pfmap-2 has an atypical activation
site (Thr-Ser-His instead of the Thr-X-Tyr usually found in
MAPKs), suggesting that the regulation of Pfmap-2 activity
may involve a kinase different from regular MEKs, with
Pfnek-1 being a potential candidate. GST±Pfnek-1 and
GST-Pfmap-2 fusion proteins have similar sizes, rendering
the interpretation of kinase assays involving both kinases
difficult. We therefore constructed a new Pfmap-2 expres-
sion plasmid, His-Pfmap-2, where the GST moiety is
substituted by a poly histidine tag (it also lacks a 97-residue
N-terminal extension, see Materials and methods). The
His-Pfmap-2 protein is approximately 45 kDa in size and is
easily distinguished from 65 kDa GST±Pfnek-1 in poly-
acrylamide gels. We performed kinase assays where the
His-Pfmap-2 protein was used in isolation (Fig. 7, lane 4)
or together with GST±Pfnek-1 (lane 5). That similar
amounts of His-Pfmap-2 protein were present was verified
by Coomassie Blue staining of the gel (lower panel). The
autoradiogram (top panel) clearly reveals that His-Pfmap-2,
which has intrinsic autophosphorylation activity as expected
from our previous experiments with GST-Pfmap-2 [5], is
labelled more efficiently (by a factor of up to 10, varying
slightly with recombinant protein preparations, as deter-
mined by densitometric analysis of autoradiograms) in the
presence of GST±Pfnek-1. In contrast, mouse GST-ERK2
labelling resulting from autophosphorylation (lane 2) was
not affected by the presence of Pfnek-1 (lane 3). Likewise,
GST-Pfmap-1, another P. falciparum MAPK, was not phos-
phorylated by GST±Pfnek-1 (data not shown). On the
autoradiogram of Fig. 7, the experimental conditions (lower
amount of enzyme and short exposure time) do not allow
detection of GST±Pfnek-1 autophosphorylation as observed
in Fig. 3A. Nevertheless, even at longer exposure times or
Fig. 6. Effect of site-directed mutagenesis of potential phos-
phorylation sites. The indicated mutant recombinant proteins were
tested for b-casein phosphorylation in a standard kinase assay (see
Materials and methods). (A) Autoradiogram. (B) Kinectics of kinase
activity of the mutated enzymes. The fact that similar amounts of
wild-type and mutant proteins were used was verified by Coomassie
blue staining (not shown). (C) Autoradiogram showing the autophos-
phorylation of the Pfnek-1 mutants.
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with higher GST±Pfnek-1 concentrations, we never observed
a higher level of phosphorylation of GST±Pfnek-1 in the
presence of His-Pfmap-2 or GST-Pfmap-2 (not shown),
which indicates that Pfnek-1 is not a substrate for the latter
enzyme.
Synergistic relationship between Pfnek-1 and Pfmap-2
kinase activities
The next step was to determine the effect of the simul-
taneous presence of both kinases on exogenous substrate
phosphorylation: if one of the enzymes is activated by the
other, one would predict in these conditions a synergistic
increase in substrate phosphorylation. We performed kinase
reactions using MBP as a substrate [this protein can be
labelled by both Pfmap-2 [5] and Pfnek-1 (Fig. 4)], either
with each kinase in isolation or with both enzymes together
in the same reaction (Fig. 8). We chose conditions such that
MBP phosphorylation by each kinase alone would yield a
low signal. When both enzymes were present in the
reaction, MBP labelling increased to an extent that was
clearly more than additive (compare the MBP signals in
lanes 1 and 2, with that of lane 3), which demonstrates a
synergistic relationship between the activities of the two
kinases. Quantification by phosphorimaging indicated that
MBP labelling in the presence of both kinases was 7- to
10-fold higher (varying with the different experiments) than
the sum of the labelling caused by the two kinases in
isolation.
D I S C U S S I O N
Very little is known about the molecular mechanisms
controlling cell growth and development in malaria
parasites. A major hindrance to progress in this field arises
from the difficulties in manipulating the parasite's genome:
although transient transfection experiments and knock-out
of genes which are not essential to the asexual erythrocytic
cycle are now possible [33], there is still no available
system for inducible expression of transfected genes, or for
inactivating genes that are essential to completion of
asexual growth. Therefore, gene function data are lagging
behind the large amount of sequence data provided by the
international P. falciparum genome sequencing project.
Nevertheless, before routine gene manipulation techniques
become available, significant information can be gained by
characterizing gene products at the biochemical level.
Having previously characterized two P. falciparum
MAPK homologues [4,5], we searched the databases of
the sequencing project to identify putative MAPKK (MEK)
homologues in the parasite's genome. Using as a query a
short region which spans the activation site of MEKs
allowed us to identify a gene encoding a protein kinase
(Pfnek-1) with high similarity to the MEKs in a short region
around the MEK activation site (Fig. 1), despite higher
overall homology to kinases of the NIMA family than to
those of the MEK family. Obviously, we cannot at this stage
exclude that true MEK orthologues are present in the
genome; completion of the sequencing project will shed
definitive light on this issue. It is worth mentioning here
that we have very recently identified in PlasmoDB an ORF
with maximal overall homology to MEKs, but with no
recognizable MEK activation site [26]; we are in the
process of investigating whether the enzyme encoded by
this new ORF has MEK activity towards Pfmap-1 (which
has a classical TXY activation site) or Pfmap-2.
Pfnek-1 is able to phosphorylate Pfmap-2, an atypical
P. falciparum MAPK, in vitro. Furthermore, the two
kinases cooperate synergistically towards exogenous sub-
strate phosphorylation. It is possible (and even likely) that
Pfmap-2 and Pfnek-1 transfer phosphate groups on different
residues of the MBP molecule; if the enzymes were
exerting their activity independently, one would predict a
mere additive effect on total MBP labelling in the presence
of the two enzymes. The clearly synergistic effect strongly
suggests that the activity of one of the enzymes is increased
in the presence of the other one. We cannot formally
exclude the possibility that phosphorylation of some resi-
dues on MBP by one of the kinase enhances the ability of
the other enzyme to phosphorylate additional residues.
Such a property of using phosphoamino acids as a
determinants for substrate specificity has been documented
in certain protein kinases, notably casein kinase 1 [34], but
not, to our knowledge, in members of the NIMA/Nek or
MAPK families (see [35]).
Important questions remain: does the Pfnek-1/Pfmap-2
synergistic cooperation correspond to a physiological
mechanism, or is it an artefact resulting from the in vitro
conditions of the assays? What is the exact mechanisms of
Fig. 7. Effect of GST±Pfnek-1 on the phosphorylation level of
His-Pfmap-2. His-Pfmap-2 (1 mg) or GST-ERK2 (0.5 mg) were
incubated in a kinase reaction with or without 100 ng of GST±
Pfnek-1. Lane 1: GST±Pfnek-1 alone; lane 2: GST-ERK2 alone; lane
3: GST±Pfnek-1 1 GST-ERK2; lane 4: His-Pfmap-2 alone; lane 5:
GST±Pfnek-1 1 His-Pfmap-2. (A) Autoradiogram of the gel (expo-
sure time was two hours); (B) Coomassie Blue staining of the same gel.
Bands corresponding to Pfnek-1 are indicated by asterisk.
Fig. 8. Synergistic kinase activities of Pfmap-2 and Pfnek-1.
GST±Pfnek-1 and GST-Pfmap-2 were incubated either alone (lane 1:
GST±Pfnek-1, lane 2: GST-Pfmap-2) or in combination (lane 3) for
30 min in a standard kinase assays using MBP as a substrate.
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synergy? The level of synergy (7- to 10-fold) is in contrast
with the strong stimulation of other MAPKs by their
respective MEK [36,37], but is in good agreement with our
previous data showing an activation of Pfmap-2 of up to
10-fold by gametocyte extracts [5]. One possibility to test
the hypothesis that Pfnek-1 activates Pfmap-2 at some stage
during sexual development would be to over-express a
dominant-negative Pfnek-1 enzyme (e.g. the K44M mutant);
however, this necessitates the development of an inducible
gene expression system in P. falciparum.
Whether or not Pfnek-1 is involved in MAPK pathway
output in vivo, it may have additional (or entirely different)
functions. The structural similarity of Pfnek-1 to the
NIMA/Nek family is extended by functional features, as
shown by (a) the ability of the enzyme to phosphorylate a
panel of substrates with a specificity which is reminiscent
of that of NIMA/Nek kinases [29], and (b) the fact that the
S200A mutation drastically affects kinase activity, similar
to the corresponding mutation (T199A) in NIM-1 from
Neurospora crassa [21]. There are, however, distinct diver-
gences between the NIMA kinases and Pfnek-1: in the
latter, the minimal phosphorylation site largely conserved
in the NIMA family, FXXT, is substituted by the SMAHS
site reminiscent of the MEK activation site (see above and
Fig. 2). Pfnek-1 also has a 20-residue insertion in the
catalytic domain (NIMA has such an insertion as well, but
it is located in a different region of the catalytic domain [9],
see Fig. 1). It is important to keep in mind that the
functional data and kinetic parameters presented here were
obtained with a recombinant protein from which the
predicted C-terminal extension had been omitted; a possible
regulatory function of this extension cannot be excluded
and deserves further investigations.
NIMA-related kinases have assumed diverse roles during
evolution, which makes it difficult to predict the function(s)
of their putative homologues in organisms as phylo-
genetically isolated as the Apicomplexa, and there is little
ground a priori to postulate precise roles for the plasmodial
kinase. The kinase with highest homology to Pfnek-1 is
mammalian Nek2, which is associated with the centrosome
[22]. In view of the unusual mechanism of spindle
formation in malaria parasites (reviewed in [3]), it will be
interesting to determine whether Pfnek-1 associates with
the centriolar plaques involved in this process.
Although our in vitro data require in vivo confirmation,
they are consistent with an emerging picture in which many
kinases involved in major signal transduction pathways in
P. falciparum have properties that are distinct from those of
their mammalian counterparts. Such divergences include
(a) primary structure peculiarities in Plasmodium MAPKs
[4,5], (b) the presence in the parasite's genome of a kinase
(PfPK6) with structural features characteristics of both
MAPKs of CDKs, which has no known mammalian
homologue [38] (this is reminiscent of the MEK-like
activation site present in an otherwise NIMA/Nek protein),
(c) the autophosphorylation capability of PfPK5 (a cdc2-
related kinase) in the presence of a cyclin [34], and (d) the
presence of a family of calcium-dependent protein kinases
(CDPKs), homologues of which are found in plants and
ciliates but not animal cells [27]. These divergences
illustrate the large phylogenetic distance between mammals
and malaria parasites (which are thought to have evolved
from photosynthetic organisms related to dinoflagellelates,
and to have lost photosynthetic capabilities upon adopting a
parasitic way of life [39]), thus lending hope that specific
interference with parasite (vs. host) regulatory pathways is
feasible. If Pfnek-1 can be shown to be essential to parasite
development, thereby representing a potential drug target,
kinase inhibition assays (Fig. 5) can readily be extended
into high-throughput screening of chemical libraries, with
hit compounds subsequently tested for their effect on the
development of the parasite ex vivo.
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